Enasidenib
Enasidenib is an orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity.
| Catalog Number | T2346 |
| Alternative Name(s) | AG-221 |
| Research Area | Metabolism |
| Molecular Formula | C19H17F6N7O |
| CAS# | 1446502-11-9 |
| SMILES | CC(C)(O)CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)-c1cccc(n1)C(F)(F)F |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Enasidenib |
| Additional Information | https://www.targetmol.com/datasheet/T2346 |
